Jansen, M. E., Rigter, T., Rodenburg, W., Fleur, T. M. C., Houwink, E. J. F., Weda, M., & Cornel, M. C. (2017). Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity. Front Pharmacol.
Chicago-tyylinen lähdeviittausJansen, Marleen E., T. Rigter, W. Rodenburg, T. M. C. Fleur, E. J. F. Houwink, M. Weda, ja Martina C. Cornel. "Review of the Reported Measures of Clinical Validity and Clinical Utility As Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity." Front Pharmacol 2017.
MLA-viiteJansen, Marleen E., et al. "Review of the Reported Measures of Clinical Validity and Clinical Utility As Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity." Front Pharmacol 2017.